Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative FLOT for Resectable Esophageal Squamous Cell Carcinoma
NCT04699994Phase 2Unknown
- Sponsor
- Keio University
- Start
- Jun 2020
- Primary completion
- Oct 2024
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, folinic acid, oxaliplatin, docetaxel in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Keio University. Status: unknown.
02
Drugs
fluorouracilfolinic acidoxaliplatindocetaxel
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04699994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04699994.